Smoking Cessation via Protocol: The Next Step

Activity Details
  • Credit Type: CPE
  • Credit Amount: 1.00
  • Cost: Free
  • Release: Feb 1, 2019
  • Expires: Oct 5, 2021
  • Estimated Time to Complete:
    1 Hour(s)
  • Average User Rating:
    ( Ratings)
Didin't officially launch until November 20, 2019

Faculty

Clark Kebodeaux Clark Kebodeaux, PharmD, BCACP
Clinical Assistant Professor
Department of Pharmacy Practice & Science
University of Kentucky, College of Pharmacy
Lexington, Kentucky

Needs Statement

Changes in legislation increased the pharmcist scope of practice related to smoking cessation. We will discuss the impact of changes of board approved protocols to pharmacist privided patient care.

Target Audience

Pharmacists

Objectives

Upon completion of this activity, participants will be able to:
1. Describe updates that guide current tobacco dependence treatment including prescription and self-care therapeutic options
2. Discuss the impact of board authorized protocols on patient care opportunities in smoking cessation
3. Evaluate a patient’s tobacco use and medical history to provide appropriate recommendations

Accreditation

CPE
ACPEThe University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This knowledge-based activity has been assigned UAN 0022-0000-18-175-H01-P and will award 1.00 contact hour (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

Statements of participation will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and/or posttest (score 70% or higher) and requesting credit online at the conclusion of the activity. Credit will be uploaded to CPE Monitor, and participants may print a statement of credit or transcript from their NABP e-profile. The College complies with the Accreditation Standards for Continuing Pharmacy Education.

Faculty Disclosure

No speakers or planners have any relevant financial relationships to disclose.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.